Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 May;1(3):317-22.
doi: 10.1177/193229680700100302.

Modeling of Calibration Effectiveness and Blood-to-Interstitial Glucose Dynamics as Potential Confounders of the Accuracy of Continuous Glucose Sensors during Hyperinsulinemic Clamp

Christopher King  1 , Stacey M Anderson, Marc Breton, William L Clarke, Boris P Kovatchev
Affiliations

Modeling of Calibration Effectiveness and Blood-to-Interstitial Glucose Dynamics as Potential Confounders of the Accuracy of Continuous Glucose Sensors during Hyperinsulinemic Clamp

Christopher King et al. J Diabetes Sci Technol. 2007 May.

Abstract

Background: Models of the dynamics of interstitial fluid-based continuous glucose sensors imply a variable sensor deviation from reference blood glucose (BG), depending on both sensor calibration procedure and BG dynamics. These effects could have a significant effect on the cross-interpretation of nonidentical accuracy studies.

Methods: Hyperinsulinemic euglycemic and hypoglycemic clamps were performed on 39 subjects with type 1 diabetes wearing the Medtronic Continuous Glucose Monitoring System®. Sensor calibration and interstitial glucose (IG) dynamics were modeled and analyzed as potential confounders of sensor deviation from reference BG.

Results: The mean absolute deviation (MAD) of sensor data was 20.9 mg/dl during euglycemia and 24.5 mg/dl during descent into and recovery from hypoglycemia. Computer-generated recalibration reduced MAD to 10.6 and 14.6 mg/dl, respectively. Modeling of IG dynamics reduced the MAD further to 10.0 and 10.4 mg/dl (using idiosyncratic parameters) or to 10.6 and 11.5 mg/dl (using model parameters common for all subjects), respectively.

Conclusions: The sensor MAD from reference is strongly influenced by the choice of calibration points. Thus, cross-experiment comparisons of sensor accuracy are likely to be heavily dependent on the employed calibration procedures. Demanding calibration points substantially differing in value was found to improve calibration effectiveness. Simulation using existing IG models and population parameters reduced the bias resulting from BG-IG dynamics.

Keywords: calibration; continuous glucose sensor; delay; hyperinsulinemic clamp; interstitial fluid; surrogate interstitial glucose.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Sensor accuracy against reference of two-point recalibration given forced difference in recalibration point values. Bottom dashed line is optimal all-point calibration; top dashed line is original device calibration.
Figure 2.
Figure 2.
Averaged time courses of CGS, BG, and SIG. Subjects are time matched by nadir of BG.
See this image and copyright information in PMC

References

    1. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005 May;28(5):1231–1239. - PubMed
    1. Hirsh IB, Brownlee M. Should minimal blood glucose variability become the gold standard of glycemic control+ J Diabetes Complications. 2005 May–Jun;19(3):178–181. - PubMed
    1. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH, Mastrototaro JJ. Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther. 2000 Spring;2(1):49–56. - PubMed
    1. Feldman B, Brazg R, Schwartz S, Weinstein R. A continuous glucose sensor based on wired enzyme technology–results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther. 2003;5(5):769–779. - PubMed
    1. Cheyne EH, Cavan DA, Kerr D. Performance of continuous glucose monitoring system during controlled hypoglycemia in healthy volunteers. Diabetes Technol Ther. 2002;4(5):607–613. - PubMed